Practical Utility of Diagnostic Clinical Breast Examination in the Diagnosis of Breast Cancer

dc.contributor.authorTuran, Muberra
dc.contributor.authorSozen, Fisun
dc.contributor.authorEminsoy, Muzaffer G.
dc.contributor.authorSencelikel, Tugce
dc.contributor.authorKut, Altug
dc.contributor.authorYildirim, Sedat
dc.contributor.authorOksuz, Ergun
dc.contributor.orcID0000-0002-5723-5965en_US
dc.contributor.pubmedID34646704en_US
dc.contributor.researcherIDK-8238-2012en_US
dc.date.accessioned2022-08-17T12:24:18Z
dc.date.available2022-08-17T12:24:18Z
dc.date.issued2021
dc.description.abstractObjectives We aimed to investigate the effectiveness of physician-performed diagnostic clinical breast examination (DCBE) for the diagnosis of breast cancer in clinical practice and to determine the rates of breast cancer diagnosed with DCBE compared to the results of breast ultrasonography (US), mammography (MG), and histopathology. Methods In the retrospective cohort study, the files of female patients diagnosed with breast cancer and admitted to the general surgery outpatient clinics of a university hospital over a 10-year period (2011-2021) were examined. Patients with complete DCBE findings in their files were identified and analyzed (n = 1,091). The examinations of the patients were performed by general surgery specialists with 5-22 years of experience and by radiologists with 4-15 years of experience. Results The mean age of breast cancer diagnosis of the patients was 55.1 +/- 13.5 years. While the sensitivity of IX:BE was found to be 88.9%, MG sensitivity was 89.8% and breast US sensitivity was 95.1%. Cancer was detected by MG, breast US, and DCBE in 47.9% (n = 523), by breast US and DCBE in 38.9% (n = 424), by MG and breast US in 5.6% (n = 61), by DCBE alone in 3.6% (n = 39), by MG and KBE in 2.4% (n = 26), and by breast US alone in 1.6% (n = 18). Early-stage breast cancer (p = 0.00) consisted of 73.2% (n = 383) of cancers detected with DCBE, breast US and MG, 74.6% (n = 316) of cancers detected with DCBE and breast US, 93.4% of cancers detected with breast US and MG (n = 57), 92.3% (n = 24) of cancers detected with DCBE and MG, 94.4% (n = 17) of cancers detected with breast US alone, and 69.2% of cancers detected with DCBE alone (n = 27). Conclusions CBE still maintains its importance in societies where screening participation and awareness of breast cancer are low. A breast cancer diagnosis is often done after a complaint of a palpable mass in the breast, and only then are more advanced-stage breast cancers are seen. CBE is among the important diagnostic methods preventing breast cancer from being overlooked, especially in places where health resources are limited.en_US
dc.identifier.eissn2168-8184en_US
dc.identifier.endpage10en_US
dc.identifier.issue9en_US
dc.identifier.startpage1en_US
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487246/pdf/cureus-0013-00000017662.pdf
dc.identifier.urihttp://hdl.handle.net/11727/7381
dc.identifier.volume13en_US
dc.identifier.wos000692108400004en_US
dc.language.isoengen_US
dc.relation.isversionof10.7759/cureus.17662en_US
dc.relation.journalCUREUSen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectphysical examinationen_US
dc.subjectbreast neoplasmsen_US
dc.subjectbreast diseasesen_US
dc.subjectmammographyen_US
dc.subjectbreast ultrasonographyen_US
dc.titlePractical Utility of Diagnostic Clinical Breast Examination in the Diagnosis of Breast Canceren_US
dc.typearticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ds84.pdf
Size:
349.61 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: